Odds ratio for knee osteoarthritis was 0.7 in MHT group versus non-MHT group in multivariable model
THURSDAY, Jan. 17, 2019 (HealthDay News) — For postmenopausal women, the prevalence of knee osteoarthritis is lower with menopausal hormone therapy (MHT) use, according to a study published online Dec. 21 in Menopause.
Jae Hyun Jung, M.D., Ph.D., from the Korea University College of Medicine in Seoul, and colleagues collected data from 4,766 postmenopausal women from the Korea National Health and Nutrition Examination Survey (2009 to 2012). MHT was defined as use of regular hormone medication for one year or more; the correlation between prevalence of knee OA and MHT was examined.
The researchers found that the odds ratio for OA was 0.7 for the MHT group versus the non-MHT group in the multiple logistic regression models.
“This cross-sectional study precludes conclusions about causal relationships, so further prospective studies and intervention trials should be undertaken to establish a causal association between knee OA and MHT,” the authors write.
Abstract/Full Text (subscription or payment may be required)
MHT Initiation May Reduce Cardiovascular Risk in Women With Vasomotor Symptoms 
Longer Reproductive Lifespan Tied to Lower Bronchiectasis Risk in Postmenopausal Women 
Midlife Onset of Increasing Pulse Pressure Not Linked to Menopause 
Estrogen Hormone Treatment May Be Beneficial for Brain Fog Symptoms in Menopausal Women 
Brain Abnormalities Identified in Children at Risk for Schizophrenia 
Cortical Atrophy in Early-Onset Alzheimer Disease Signature Can Predict Progression to Dementia 
Menopausal Hormone Therapy Use Linked to Lower Risk for Alzheimer Disease 
AMH Predicts Benefit of Chemo + Endocrine Therapy in Under 55s With Breast Cancer 
